Nxera Pharma Co., Ltd. (4565.T)
JPY 1056.0
(1.15%)
JPY 1056.0
(1.15%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 12.76 Billion | 15.56 Billion | 17.71 Billion | 8.84 Billion | 9.72 Billion | 3.82 Billion |
| Cost of Revenue | 3.1 Billion | 926 Million | 933 Million | 761 Million | 851 Million | 1.81 Billion |
| Gross Profit | 9.66 Billion | 14.64 Billion | 16.77 Billion | 8.08 Billion | 8.87 Billion | 2.01 Billion |
| Operating Expenses | 19.19 Billion | 11.2 Billion | 13 Billion | 7.15 Billion | 8.49 Billion | 9.41 Billion |
| Selling, General and Administrative Expenses | 9.96 Billion | 4.37 Billion | 3.94 Billion | 3.43 Billion | 3.61 Billion | 2.23 Billion |
| Research and Development Expenses | 10.07 Billion | 7.45 Billion | 5.93 Billion | 3.79 Billion | 4.29 Billion | 7.17 Billion |
| Other Expenses | - | -624 Million | 3.13 Billion | -75 Million | 585 Million | - |
| Cost and Expenses | 22.29 Billion | 12.13 Billion | 13.93 Billion | 7.91 Billion | 9.34 Billion | 11.23 Billion |
| Operating Income | -9.52 Billion | 3.67 Billion | 4.02 Billion | 2.2 Billion | 1.02 Billion | -7.4 Billion |
| Interest Expense | 2.49 Billion | 756 Million | 3.79 Billion | 578 Million | 493 Million | - |
| Income Tax Expense | -3.48 Billion | 696 Million | -584 Million | 143 Million | -898 Million | -1.68 Billion |
| Earnings before Tax | -10.68 Billion | 1.07 Billion | 433 Million | 1.62 Billion | 534 Million | -9.63 Billion |
| Net Income | -7.19 Billion | 382 Million | 1.01 Billion | 1.47 Billion | 1.43 Billion | -7.94 Billion |
| Earnings Per Share Basic | -87.17 | 4.67 | 12.53 | 18.78 | 18.69 | -104.29 |
| Earnings Per Share Diluted | -87.17 | 4.63 | 12.40 | 18.61 | 18.48 | -104.24 |
| Weighted Average Shares Outstanding | 82.51 Million | 81.78 Million | 81.18 Million | 78.73 Million | 76.62 Million | 76.2 Million |
| Weighted Average Shares Outstanding (Diluted) | 82.51 Million | 82.59 Million | 82 Million | 79.49 Million | 77.48 Million | 76.23 Million |
| Gross Margin | 0.76 | 0.94 | 0.95 | 0.91 | 0.91 | 0.53 |
| EBIT Margin | -0.58 | 0.32 | 0.30 | 0.40 | 0.26 | -1.57 |
| Profit Margin | -0.56 | 0.02 | 0.06 | 0.17 | 0.15 | -2.08 |
| EBITDA | -7.39 Billion | 5.01 Billion | 8.18 Billion | 2.2 Billion | 2.44 Billion | -6.41 Billion |
| Earnings Before Tax Margin | -0.75 | 0.24 | 0.23 | 0.25 | 0.11 | -1.93 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 9.26 Billion | 8.1 Billion | 4.61 Billion | 12.76 Billion | 7.29 Billion | 3.32 Billion |
| Cost of Revenue | 2.99 Billion | 3.3 Billion | 2.17 Billion | 4.9 Billion | 2.52 Billion | 1.12 Billion |
| Gross Profit | 6.27 Billion | 4.8 Billion | 2.43 Billion | 7.86 Billion | 4.77 Billion | 2.2 Billion |
| Operating Expenses | 5.73 Billion | 5.69 Billion | 5.83 Billion | 16.92 Billion | 6.25 Billion | 6.02 Billion |
| Selling, General and Administrative Expenses | 2.7 Billion | 3.36 Billion | 2.66 Billion | - | 3.19 Billion | 3.44 Billion |
| Research and Development Expenses | 3.03 Billion | 2.32 Billion | 3.16 Billion | - | 3.06 Billion | 2.97 Billion |
| Other Expenses | - | -310 Million | - | - | - | - |
| Cost and Expenses | 8.72 Billion | 8.99 Billion | 8 Billion | 21.82 Billion | 8.77 Billion | 7.15 Billion |
| Operating Income | 541 Million | -888 Million | -3.39 Billion | -9.06 Billion | -1.48 Billion | -3.45 Billion |
| Interest Expense | 195 Million | 199 Million | 185 Million | 2.49 Billion | 1.63 Billion | 646 Million |
| Income Tax Expense | -335 Million | 1.06 Billion | 485 Million | -3.48 Billion | -2.6 Billion | 820 Million |
| Earnings before Tax | 865 Million | -362 Million | -2.79 Billion | -10.68 Billion | -2.81 Billion | -4.1 Billion |
| Net Income | 1.2 Billion | -1.42 Billion | -3.28 Billion | -7.19 Billion | -208 Million | -4.92 Billion |
| Earnings Per Share Basic | 13.35 | -15.86 | -36.68 | - | -2.33 | -59.82 |
| Earnings Per Share Diluted | 13.35 | -15.86 | -36.68 | - | -2.33 | -59.82 |
| Weighted Average Shares Outstanding | 89.9 Million | 89.67 Million | 89.44 Million | 82.51 Million | 89.44 Million | 82.33 Million |
| Weighted Average Shares Outstanding (Diluted) | 89.9 Million | 89.67 Million | 89.44 Million | 82.51 Million | 89.44 Million | 82.33 Million |
| Gross Margin | 0.68 | 0.59 | 0.53 | 0.62 | 0.65 | 0.66 |
| EBIT Margin | 0.22 | 0.01 | -0.52 | - | -0.07 | -0.80 |
| Profit Margin | 0.13 | -0.18 | -0.71 | -0.56 | -0.03 | -1.48 |
| EBITDA | 2.05 Billion | 116 Million | -2.41 Billion | - | -500 Million | -2.66 Billion |
| Earnings Before Tax Margin | 0.06 | -0.11 | -0.74 | -0.71 | -0.20 | -1.04 |
3738
VIJAYA
8107
6504
CVGI
0I7E